![]() H-Arg-Gly-Asp-Val-OH structure
|
Common Name | H-Arg-Gly-Asp-Val-OH | ||
---|---|---|---|---|
CAS Number | 93674-99-8 | Molecular Weight | 445.47100 | |
Density | 1.57g/cm3 | Boiling Point | 821.1ºC at 760 mmHg | |
Molecular Formula | C17H31N7O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 450.4ºC |
Use of H-Arg-Gly-Asp-Val-OHRGDV is a platelet aggregation inhibitor. RGDV inhibits platelet-dependent thrombus formation. RGDV is used for tumor recognition via the targeting effect[1][2]. |
Name | (2S)-2-[[(2S)-2-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid |
---|---|
Synonym | More Synonyms |
Description | RGDV is a platelet aggregation inhibitor. RGDV inhibits platelet-dependent thrombus formation. RGDV is used for tumor recognition via the targeting effect[1][2]. |
---|---|
Related Catalog | |
In Vitro | RGDV (25-100 nM; thrombus vessel model) selectively inhibits platelet-dependent thrombus formation and decreases the accumulation of both platelets and fibrin on the collagen substrate in a dose-response manner[1]. |
References |
Density | 1.57g/cm3 |
---|---|
Boiling Point | 821.1ºC at 760 mmHg |
Molecular Formula | C17H31N7O7 |
Molecular Weight | 445.47100 |
Flash Point | 450.4ºC |
Exact Mass | 445.22800 |
PSA | 249.82000 |
Index of Refraction | 1.644 |
Rgdv tetrapeptide |
Arg-gly-asp-val |
Arginyl-glycyl-aspartyl-valine |
L-Arginylglycyl-L-alpha-Aspartyl-L-Valine |